Correlation Between Denali Therapeutics and Aditxt

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Aditxt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Aditxt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Aditxt Inc, you can compare the effects of market volatilities on Denali Therapeutics and Aditxt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Aditxt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Aditxt.

Diversification Opportunities for Denali Therapeutics and Aditxt

  Correlation Coefficient

Good diversification

The 3 months correlation between Denali and Aditxt is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Aditxt Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aditxt Inc and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Aditxt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aditxt Inc has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Aditxt go up and down completely randomly.

Pair Corralation between Denali Therapeutics and Aditxt

Given the investment horizon of 90 days Denali Therapeutics is expected to generate 1100.79 times less return on investment than Aditxt. But when comparing it to its historical volatility, Denali Therapeutics is 14.93 times less risky than Aditxt. It trades about 0.0 of its potential returns per unit of risk. Aditxt Inc is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3,480  in Aditxt Inc on June 23, 2023 and sell it today you would lose (1,683) from holding Aditxt Inc or give up 48.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Denali Therapeutics  vs.  Aditxt Inc

Denali Therapeutics 

Denali Performance

0 of 100
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in October 2023. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Aditxt Inc 

Aditxt Performance

6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Aditxt Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Aditxt showed solid returns over the last few months and may actually be approaching a breakup point.

Denali Therapeutics and Aditxt Volatility Contrast

   Predicted Return Density   

Pair Trading with Denali Therapeutics and Aditxt

The main advantage of trading using opposite Denali Therapeutics and Aditxt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Aditxt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aditxt will offset losses from the drop in Aditxt's long position.
The idea behind Denali Therapeutics and Aditxt Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Directory
Find actively traded corporate debentures issued by US companies
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements